📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
2 articles
AVG GRADE
HIGH
score: 0.50
SENTIMENT
BEARISH
TOTAL VIEWS
1
2-DAY GRADE TIMELINE
2026-06-11
TODAY
RECENT COVERAGE · 6 ARTICLES
Viridian Therapeutics: Lumvoa Ready For Prime Time Following FDA Approval (NASDAQ:VRDN)
Viridian Therapeutics (VRDN) has achieved a significant regulatory milestone with FDA approval of Lumvoa for thyroid eye disease...
Nearly 1 million bottles of heart and kidney medication recalled over foreign substance found on tablets
Amgen initiated a recall of approximately 1 million bottles of Corlanor (ivabradine) and Sensipar (cinacalcet) following FDA...
Amgen Continues To Perform (NASDAQ:AMGN)
Amgen (AMGN) continues demonstrating operational resilience with analyst sentiment tilted toward constructive valuations. The...
Obesity drugs approach a major milestone, and Lilly may have a 'game changer' ahead
Eli Lilly (LLY) appears positioned for a significant catalyst event tied to obesity drug advancement. The reference to an imminent "game...
Harbour BioMed Secures Landmark Victory in U.S. Patent Infringement Case Against Amgen, Reshaping the Global Antibody Patent Landscape
A Delaware jury has delivered a significant intellectual property loss for Amgen, finding willful infringement of Harbour BioMed's...
7 Best Longevity Stocks to Buy Now
The article highlights a thematic investment thesis centered on longevity stocks, reflecting growing institutional interest in companies...
RELATED TICKERS
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice